Acute liver failure
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
all patients
intensive care management
Patients with ALF with grade 2 or higher hepatic encephalopathy should be admitted to an intensive care unit (ICU).[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com The natural history of ALF may be characterised by a rapid deterioration in neurological status, high risk of complications including sepsis and cerebral oedema, haemodynamic instability, and renal failure. Intensive care unit monitoring is critical in providing optimal care of the patient and to prevent and treat known complications of ALF.
Efforts should be made to minimise elevations of intracranial pressure. The head of the patient's bed should be raised to approximately 30 degrees and surrounding stimuli reduced to a minimum.[51]Wendon J, Cordoba J, Dhawan A, et al; European Association for the Study of the Liver. EASL clinical practical guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017 May;66(5):1047-81. https://www.journal-of-hepatology.eu/article/S0168-8278(16)30708-5/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28417882?tool=bestpractice.com Once advanced encephalopathy develops (grades 3 or 4), tracheal intubation should be performed for airway protection.[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com Propofol and fentanyl are preferred agents for analgesia and sedation due to their short half-lives. Intravenous fluids should be administered with caution to prevent depletion or volume overload; central venous pressure and pulmonary arterial monitoring as well as renal replacement therapy should be considered early to ensure optimal fluid management, particularly if there is evidence of renal or circulatory dysfunction.[8]American Association for the Study of Liver Diseases. AASLD position paper: the management of acute liver failure: update 2011. Nov 2011 [internet publication]. https://www.aasld.org/practice-guidelines/management-acute-liver-failure [100]Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007 Nov;35(11):2498-508. http://www.ncbi.nlm.nih.gov/pubmed/17901832?tool=bestpractice.com
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Enteral nutrition is generally a concern in the setting of encephalopathy, in which the patient is unable to obtain adequate nutrition due to an altered mental status. Therefore, enteral nutritional support with calorie-dense feeds should also be initiated early during the hospital course.
Prophylactic antimicrobial therapy does not appear to influence outcome and is not recommended.[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com [104]Karvellas CJ, Cavazos J, Battenhouse H, et al; US Acute Liver Failure Study Group. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol. 2014 Nov;12(11):1942-9.e1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205208 http://www.ncbi.nlm.nih.gov/pubmed/24674942?tool=bestpractice.com However, empirical antimicrobials are recommended if a patient develops positive surveillance cultures, refractory hypotension, progression to grade 3 to 4 hepatic encephalopathy, evidence of Systemic Inflammatory Response Syndrome; and in all patients who are listed for liver transplantation.[100]Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007 Nov;35(11):2498-508. http://www.ncbi.nlm.nih.gov/pubmed/17901832?tool=bestpractice.com
Proton-pump inhibitors or H2 antagonists should be administered as prophylaxis of gastrointestinal bleeding secondary to coagulopathy.[8]American Association for the Study of Liver Diseases. AASLD position paper: the management of acute liver failure: update 2011. Nov 2011 [internet publication]. https://www.aasld.org/practice-guidelines/management-acute-liver-failure
liver transplantation assessment
Treatment recommended for ALL patients in selected patient group
Criteria for United Network for Organ Sharing (UNOS) Status 1A designation include: age >18 years, life expectancy without a liver transplant of <7 days, onset of encephalopathy within 8 weeks of the first symptoms of liver disease, absence of pre-existing liver disease, admission to an intensive care unit, and 1 of the following: ventilator dependence, requirement of renal replacement therapy, or INR >2.0. UNOS status 1A patients are listed with top priority for liver allocation. Wilson's disease may also be given Status 1A priority.
Contraindications to liver transplantation include severe cardiac or pulmonary disease, AIDS, extrahepatic malignancy, metastatic hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uncontrolled sepsis, irreversible neurological complications (e.g., brain death, intracerebral haemorrhage, intractable sustained raised intracranial pressure), ongoing alcohol or illicit substance misuse, and lack of an adequate social support system.[48]American Association for the Study of Liver Diseases. Evaluation for liver transplantation in adults: 2013 practice guideline by AASLD and AST. March 2014 [internet publication]. https://www.aasld.org/practice-guidelines/evaluation-adult-liver-transplant-patient
Ultrasound-guided insertion of a non-tunnelled central venous catheter (CVC) into the right internal jugular vein using the Seldinger insertion technique.
neurological status monitoring for advanced encephalopathy
Treatment recommended for ALL patients in selected patient group
Neurological status should be monitored carefully and regularly for the development of advanced encephalopathy (grade 3 to 4), which is associated with a greater risk of cerebral oedema and intracranial hypertension.
Head of the patient's bed should be raised to 30 degrees and surrounding stimuli reduced. Tracheal intubation and sedation with intravenous propofol or fentanyl should be performed once advanced encephalopathy develops. Central venous pressure monitoring, pulmonary arterial monitoring, and renal replacement therapy should be considered early.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
monitoring of blood glucose, electrolytes, and cultures
Treatment recommended for ALL patients in selected patient group
Blood glucose levels should be monitored every 1 to 2 hours by finger stick to assess for hypoglycaemia. Hypoglycaemia should be corrected with intravenous glucose infusion, with a glycaemic target of 140 mg/dL.[51]Wendon J, Cordoba J, Dhawan A, et al; European Association for the Study of the Liver. EASL clinical practical guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017 May;66(5):1047-81. https://www.journal-of-hepatology.eu/article/S0168-8278(16)30708-5/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28417882?tool=bestpractice.com
Serum electrolytes, including sodium, phosphate, potassium, and magnesium, should be monitored at least twice daily and corrected aggressively.
In patients with advanced encephalopathy (grade 3 or 4), surveillance cultures from blood, urine, and sputum should be obtained periodically given the high risk of bacterial and fungal infection; however, no clear impact of prophylactic antimicrobials has been shown.
Other routine laboratory studies such as coagulation activity, blood cell counts, and liver enzymes should also be monitored closely at regular intervals.
acetylcysteine
Treatment recommended for ALL patients in selected patient group
Acetylcysteine therapy should be given in all cases of paracetamol overdose regardless of the dose or timing of paracetamol ingestion. See Paracetamol overdose.
Acetylcysteine therapy is also recommended for patients with mild to moderate hepatic encephalopathy, even when paracetamol has not been ingested.[105]Stravitz RT. Critical management decisions in patients with acute liver failure. Chest. 2008 Nov;134(5):1092-102. http://www.ncbi.nlm.nih.gov/pubmed/18988787?tool=bestpractice.com Based on available evidence, the American College of Gastroenterology recommends using intravenous acetylcysteine in patients with non-paracetamol ALF.[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com In particular, a short course of intravenous acetylcysteine may be of benefit for hospitalised adult patients with ALF secondary to a drug-induced liver injury, but it is not recommended in children.[30]Fontana RJ, Liou I, Reuben A, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2022 Jul 27 [Epub ahead of print]. https://www.doi.org/10.1002/hep.32689 http://www.ncbi.nlm.nih.gov/pubmed/35899384?tool=bestpractice.com
Oral acetylcysteine may be given in patients with up to grade 1 hepatic encephalopathy. Intravenous acetylcysteine is preferred for higher grades of hepatic encephalopathy or if the patient is intolerant of oral intake, has ileus or is pregnant, and should be accompanied by telemetry monitoring.[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com [30]Fontana RJ, Liou I, Reuben A, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2022 Jul 27 [Epub ahead of print]. https://www.doi.org/10.1002/hep.32689 http://www.ncbi.nlm.nih.gov/pubmed/35899384?tool=bestpractice.com
Acetylcysteine therapy should continue until end points such as improvement of hepatic function by clinical and laboratory parameters have been achieved.[23]Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med. 2008 Jul 17;359(3):285-92. http://www.ncbi.nlm.nih.gov/pubmed/18635433?tool=bestpractice.com [30]Fontana RJ, Liou I, Reuben A, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2022 Jul 27 [Epub ahead of print]. https://www.doi.org/10.1002/hep.32689 http://www.ncbi.nlm.nih.gov/pubmed/35899384?tool=bestpractice.com [100]Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007 Nov;35(11):2498-508. http://www.ncbi.nlm.nih.gov/pubmed/17901832?tool=bestpractice.com
Primary options
acetylcysteine: consult specialist for guidance on dose
activated charcoal
Additional treatment recommended for SOME patients in selected patient group
In patients with paracetamol overdose in whom ingestion is known to have occurred within 4 hours, a single-dose of activated charcoal can be given.[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com
Primary options
activated charcoal: 25-100 g orally as a single dose
aciclovir
Treatment recommended for ALL patients in selected patient group
May have positive impact on clinical outcome.[8]American Association for the Study of Liver Diseases. AASLD position paper: the management of acute liver failure: update 2011. Nov 2011 [internet publication]. https://www.aasld.org/practice-guidelines/management-acute-liver-failure
Primary options
aciclovir: 10 mg/kg intravenously every 8 hours
expedient delivery of the fetus
Treatment recommended for ALL patients in selected patient group
Prompt delivery of the fetus may have a positive impact on clinical outcome.[8]American Association for the Study of Liver Diseases. AASLD position paper: the management of acute liver failure: update 2011. Nov 2011 [internet publication]. https://www.aasld.org/practice-guidelines/management-acute-liver-failure In addition to this approach, supportive care and multidisciplinary management are recommended.[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com If patient’s condition fails to improve after delivery, liver transplantation may be considered.
intravenous fluids + gastric lavage + activated charcoal
Treatment recommended for ALL patients in selected patient group
Contact the poison control centre for guidance. Continued supportive management includes intravenous fluids.[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com
Primary options
activated charcoal: 25-100 g as a single dose, repeat every 4-6 hours if required
benzylpenicillin
Treatment recommended for ALL patients in selected patient group
Amatoxins inhibit hepatocyte RNA polymerase II, leading to cell necrosis. Beta-lactam antibiotics are thought to be hepatoprotective in the setting of amanita toxicity. This has been reported through in vitro experiments, studies with animal models, and in the clinical setting following Amanita phalloides ingestion by humans, in which intravenous penicillin has been associated with clinical recovery and improved survival. The exact mechanism has not been well defined; however, it may be associated with blocking of amatoxin uptake by hepatocytes.[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com [30]Fontana RJ, Liou I, Reuben A, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2022 Jul 27 [Epub ahead of print]. https://www.doi.org/10.1002/hep.32689 http://www.ncbi.nlm.nih.gov/pubmed/35899384?tool=bestpractice.com [100]Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007 Nov;35(11):2498-508. http://www.ncbi.nlm.nih.gov/pubmed/17901832?tool=bestpractice.com [123]Letschert K, Faulstich H, Keller D, et al. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci. 2006 May;91(1):140-9. http://www.ncbi.nlm.nih.gov/pubmed/16495352?tool=bestpractice.com [124]Enjalbert F, Rapior S, Nouguier-Soulé J, et al. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol. 2002;40(6):715-57. http://www.ncbi.nlm.nih.gov/pubmed/12475187?tool=bestpractice.com
Primary options
benzylpenicillin sodium: 2.4 to 4.8 g/day intravenously in 4 divided doses
acetylcysteine
Treatment recommended for ALL patients in selected patient group
Oral acetylcysteine may be given in patients with up to grade 1 hepatic encephalopathy. Intravenous acetylcysteine is preferred for higher grades of hepatic encephalopathy, or if the patient is intolerant to oral intake, has ileus or is pregnant; telemetry monitoring is recommended for intravenous dosing.
Acetylcysteine therapy should continue until end points such as improvement of hepatic function by clinical and laboratory parameters have been achieved.[23]Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med. 2008 Jul 17;359(3):285-92. http://www.ncbi.nlm.nih.gov/pubmed/18635433?tool=bestpractice.com [30]Fontana RJ, Liou I, Reuben A, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2022 Jul 27 [Epub ahead of print]. https://www.doi.org/10.1002/hep.32689 http://www.ncbi.nlm.nih.gov/pubmed/35899384?tool=bestpractice.com [100]Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007 Nov;35(11):2498-508. http://www.ncbi.nlm.nih.gov/pubmed/17901832?tool=bestpractice.com
Primary options
acetylcysteine: consult specialist for guidance on dose
methylprednisolone
Treatment recommended for ALL patients in selected patient group
In acute presentations of autoimmune hepatitis resulting in ALF, corticosteroids may have some benefit; however, data are conflicting.[7]Lee WM, Squires RH Jr, Nyberg SL, et al. Acute liver failure: summary of a workshop. Hepatology. 2008 Apr;47(4):1401-15. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381946 http://www.ncbi.nlm.nih.gov/pubmed/18318440?tool=bestpractice.com [111]Karkhanis J, Verna EC, Chang MS, et al; Acute Liver Failure Study Group. Steroid use in acute liver failure. Hepatology. 2014 Feb;59(2):612-21. http://www.ncbi.nlm.nih.gov/pubmed/23929808?tool=bestpractice.com In the absence of clear prospective data, this potential benefit is uncertain.
Primary options
methylprednisolone sodium succinate: 60 mg intravenously once daily
oral nucleoside or nucleotide analogue
Treatment recommended for ALL patients in selected patient group
Studies are limited, although antiviral therapy may have benefit and should be considered. Entecavir or tenofovir are the preferred agents.
Primary options
entecavir: 0.5 mg orally/nasogastrically once daily
OR
tenofovir disoproxil: 300 mg orally/nasogastrically once daily
anticoagulation
Treatment recommended for ALL patients in selected patient group
Patients should be assessed for an underlying hypercoagulable disorder or myeloproliferative disease. Anticoagulation therapy (e.g., low-molecular-weight heparin) should be initiated in all patients.[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com
Budd-Chiari syndrome is defined by hepatic outflow obstruction secondary to thrombosis at the level of the hepatic veins or suprahepatic inferior vena cava in the absence of cardiac disease. A key factor in the pathogenesis of Budd-Chiari syndrome is the presence of an underlying prothrombotic condition, which can be identified in the majority of cases. Thus, all patients presenting with Budd-Chiari syndrome should be considered for immediate anticoagulation therapy.
transjugular intrahepatic portosystemic shunt (TIPS)
Additional treatment recommended for SOME patients in selected patient group
Hepatic vein angioplasty with stent or transjugular intrahepatic portosystemic shunt (TIPS) placement may be considered in patients not responding to anticoagulation.[4]Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53. https://journals.lww.com/ajg/fulltext/2023/07000/acute_liver_failure_guidelines.14.aspx http://www.ncbi.nlm.nih.gov/pubmed/37377263?tool=bestpractice.com However, some may ultimately require liver transplantation.
measures to decrease serum copper
Additional treatment recommended for SOME patients in selected patient group
Acute Wilson's disease with ALF is associated with high mortality despite measures to decrease serum copper levels, including plasmapheresis, continuous veno-venous haemofiltration, albumin dialysis, or plasma exchange. Chelation therapy for Wilson's disease in the setting of ALF is generally ineffective, may be associated with hypersensitivity, and is not recommended.
liver transplant
Treatment recommended for ALL patients in selected patient group
Wilson's disease should be suspected in any patient presenting with ALF with non-immune haemolytic anaemia including acute intravascular haemolysis. These patients should be urgently evaluated for liver transplantation.[43]Schilsky ML, Roberts EA, Bronstein JM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: executive summary of the 2022 practice guidance on Wilson disease from the American Association for the study of liver diseases. Hepatology. 2023 Apr 1;77(4):1428-55. https://journals.lww.com/hep/fulltext/2023/04000/a_multidisciplinary_approach_to_the_diagnosis_and.32.aspx
Patients with ALF who fulfil listing criteria, according to the United Network for Organ Sharing (UNOS), may be assigned category Status 1A and listed with top priority for liver allocation. Criteria for UNOS Status 1A designation include: age >18 years, life expectancy without a liver transplant of <7 days, onset of encephalopathy within 8 weeks of the first symptoms of liver disease, absence of pre-existing liver disease, admission to an intensive care unit, and 1 of the following: ventilator dependence, requirement of renal replacement therapy, or INR >2.0. Patients with acute fulminant Wilson's disease may also be given Status 1A priority.
Contraindications to liver transplantation for ALF include severe cardiac or pulmonary disease, AIDS, extrahepatic malignancy, metastatic hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uncontrolled sepsis, irreversible neurological complications (e.g., brain death, intracerebral haemorrhage, intractable sustained raised intracranial pressure), ongoing alcohol or illicit substance misuse, and lack of an adequate social support system.[48]American Association for the Study of Liver Diseases. Evaluation for liver transplantation in adults: 2013 practice guideline by AASLD and AST. March 2014 [internet publication]. https://www.aasld.org/practice-guidelines/evaluation-adult-liver-transplant-patient
Ultrasound-guided insertion of a non-tunnelled central venous catheter (CVC) into the right internal jugular vein using the Seldinger insertion technique.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer